药明生物落子中东，全球化再添里程碑

制药网12-03 19:00

药明生物作为全球生物制药产业链上的“稀缺资源”，CRDMO模式再一次受到认可。12月2日，药明生物宣布，已与卡塔尔自由区管理局(QFZ)签署战略合作备忘录，将全球服务网络与专业业务能力拓展至中东地区。药明生物相关人士表示，此次合作是药明生物全球化战略布局中的重要里程碑。卡塔尔对生物医药产业的前瞻性布局，与卡塔尔自由区管理局构建的完善产业生态，为公司生物药创新研发与先进生产构筑了重要的发展契机。此次...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2588026334?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-12-03 19:00","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2588026334","market":"hk","top_or_hot":-1,"title":"药明生物落子中东，全球化再添里程碑","media":"制药网","content":"<div>\n<p>药明生物作为全球生物制药产业链上的“稀缺资源”，CRDMO模式再一次受到认可。12月2日，药明生物宣布，已与卡塔尔自由区管理局(QFZ)签署战略合作备忘录，将全球服务网络与专业业务能力拓展至中东地区。药明生物相关人士表示，此次合作是药明生物全球化战略布局中的重要里程碑。卡塔尔对生物医药产业的前瞻性布局，与卡塔尔自由区管理局构建的完善产业生态，为公司生物药创新研发与先进生产构筑了重要的发展契机。此次...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251203190314a4ca4122&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>药明生物落子中东，全球化再添里程碑</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n药明生物落子中东，全球化再添里程碑\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-12-03 19:00 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251203190314a4ca4122&s=b><strong>制药网</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>药明生物作为全球生物制药产业链上的“稀缺资源”，CRDMO模式再一次受到认可。12月2日，药明生物宣布，已与卡塔尔自由区管理局(QFZ)签署战略合作备忘录，将全球服务网络与专业业务能力拓展至中东地区。药明生物相关人士表示，此次合作是药明生物全球化战略布局中的重要里程碑。卡塔尔对生物医药产业的前瞻性布局，与卡塔尔自由区管理局构建的完善产业生态，为公司生物药创新研发与先进生产构筑了重要的发展契机。此次...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251203190314a4ca4122&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU0307460666.USD","symbol_name":"EASTSPRING INVESTMENTS CHINA EQUITY \"A\" ACC","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251203190314a4ca4122&s=b","article_id":"2588026334","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251203190314a4ca4122&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2588026334","pubTimestamp":1764759651,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"药明生物相关人士表示，此次合作是药明生物全球化战略布局中的重要里程碑。卡塔尔将是中国以外，以及爱尔兰、德国、美国和新加坡后，药明生物全球网络中的第六极。此次药明生物落子中东，不仅在于企业自身的版图扩张，更在于为全球生物药创新构建了更高效的协作网络，为医药创新成果更快惠及全球患者提供了坚实保障。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"LU0307460666.USD":"EASTSPRING INVESTMENTS CHINA EQUITY \"A\" ACC","BK1521":"挪威政府全球养老基金持仓","LU0516422952.EUR":"FULLERTON LUX FUNDS - ASIA FOCUS EQUITIES \"I\" (EUR) ACC","LU0823426480.USD":"法巴中国股票经典Dis","LU0043850808.USD":"HSBC GIF ASIA EX JAPAN EQUITY \"AD\" INC","LU0588546209.SGD":"Eastspring Investments - China Equity Fund AS SGD","LU0823426308.USD":"法巴中国股票基金","LU1242518931.SGD":"Fullerton Lux Funds - Asia Absolute Alpha A Acc SGD","LU0348735423.USD":"ALLIANZ HONG KONG EQUITY \"A\" (USD) INC","LU1880383366.USD":"东方汇理中国股票基金 A2 (C)","LU0856984785.SGD":"HSBC GIF MANAGED SOLUTIONS ASIA FOCUSED GROWTH \"ACH\" (SGDHDG) ACC","LU0359201612.USD":"贝莱德中国基金A2","BK1589":"北水核心资产","LU0456846285.SGD":"JPMorgan Funds - Greater China A (acc) SGD","LU0979878070.USD":"FULLERTON LUX FUNDS - ASIA ABSOLUTE ALPHA \"A\" (USD) ACC","SG9999002562.SGD":"LionGlobal Asia Pacific SGD","LU0359202008.SGD":"Blackrock China Fund A2 SGD-H","LU0819121731.USD":"HSBC GIF MANAGED SOLUTIONS ASIA FOCUSED GROWTH \"AC\" (USD) ACC","LU0051755006.USD":"摩根大通中国A (dist)","LU1688375341.USD":"贝莱德中国灵活股票基金","LU0320764599.SGD":"FTIF - Templeton China A Acc SGD","SG9999002463.SGD":"LionGlobal China Growth SGD","LU0516422366.SGD":"Fullerton Lux Funds - Asia Focus Equities A Acc SGD","LU0326950275.SGD":"Schroder ISF China Opportunities A Acc SGD-H","LU0181495838.USD":"施罗德新兴亚洲A Acc","LU0456827905.SGD":"JPMorgan Funds - China A (acc) SGD","LU0572944931.SGD":"Janus Henderson Horizon China Opportunities A2 SGD","BK1141":"生命科学工具和服务","BK1576":"医药外包概念","LU0417516902.SGD":"Allianz China Equity Cl AT Acc SGD","LU1720050803.USD":"安联全方位中国股票基金","LU0516423091.SGD":"FULLERTON LUX FUNDS - ASIA FOCUS EQUITIES \"I\" (SGD) ACC","LU0052750758.USD":"富兰克林中国基金A Acc","BK1610":"ETF&股票定投概念","LU0348825331.USD":"ALLIANZ CHINA EQUITY \"A\" (USD) INC","02269":"药明生物","IE00B0JY6N72.USD":"PINEBRIDGE GLOBAL EMERGING MARKETS FOCUS EQUITY \"A\" (USD) ACC","LU1794554557.SGD":"Allianz All China Equity AT Acc H2-SGD","LU0708995583.HKD":"TEMPLETON CHINA \"A\" (HKD) ACC","LU2039709279.SGD":"MANULIFE GF DRAGON GROWTH \"AA\" (SGDHDG) INC","LU3063872942.SGD":"FULLERTON LUX FUNDS ASIA EQUITIES \"I\" (SGD) ACC","LU0516422440.USD":"FULLERTON LUX FUNDS - ASIA FOCUS EQUITIES \"A\" (USD) ACC","LU1242518857.USD":"FULLERTON LUX FUNDS - ASIA ABSOLUTE ALPHA \"I\" (USD) ACC","LU0327786744.USD":"Janus Henderson Horizon China Opportunities A2 USD","LU0516423174.USD":"FULLERTON LUX FUNDS - ASIA FOCUS EQUITIES \"I\" (USD) ACC","LU0039217434.USD":"HSBC GIF CHINESE EQUITY \"AD\" INC","LU0417516738.SGD":"Allianz Hong Kong Equity AT Acc SGD","LU0140636845.USD":"施罗德大中华区股票A Acc"},"translate_title":"WuXi Biologics settles in the Middle East, adding another milestone to globalization","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02269":1.5},"content_text":"药明生物作为全球生物制药产业链上的“稀缺资源”，CRDMO模式再一次受到认可。12月2日，药明生物宣布，已与卡塔尔自由区管理局(QFZ)签署战略合作备忘录，将全球服务网络与专业业务能力拓展至中东地区。药明生物相关人士表示，此次合作是药明生物全球化战略布局中的重要里程碑。卡塔尔对生物医药产业的前瞻性布局，与卡塔尔自由区管理局构建的完善产业生态，为公司生物药创新研发与先进生产构筑了重要的发展契机。此次合作深度整合了药明生物获全球认可的一站式CRDMO解决方案、前沿的创新技术平台，以及在复杂生物药领域的专业优势(涵盖双特异性及多特异性抗体、抗体偶联药物等)，准确呼应卡塔尔在生物医药产业发展领域的战略愿景。公开信息显示，药明生物目前规划产能超过50万升，其中海外产能占比近半。卡塔尔将是中国以外，以及爱尔兰、德国、美国和新加坡后，药明生物全球网络中的第六极。据悉，在爱尔兰敦多克，药明生物敦多克基地此前PPQ生产成功率高，近期已实现头个客户创新生物药产品通过EMA批准进行商业化生产。在新加坡，其建设中的药明生物CRDMO中心将成为公司服务亚太市场及全球市场的重要支点。在美国，药明生物马萨诸塞州伍斯特基地将与新泽西州的克兰伯里基地、波士顿的研究服务中心形成联动效应，为全球客户提供端到端赋能。如今随着又一座CRDMO中心的布局，药明生物全球辐射能力将再次得到增强。这也契合了公司CRDMO+战略中的Global+，不断提升全球网络。数据显示，塔尔不仅是进入拥有超5000万人口、药品需求旺盛的GCC(海湾合作委员会，成员国包括沙特、阿联酋、卡塔尔、科威特、阿曼、巴林)市场的门户，更地处亚、欧、非三大洲交汇处，是连接中东与世界的战略要地。在全球生物制药行业面临变革与不确定性的背景下，药明生物的全球布局展现出独特价值。当前医疗需求持续增长，地缘格局日趋复杂，药企对供应链稳定性、研发效率的要求不断提升。药明生物通过“Global+”战略，在全球关键区域构建生产和研发基地，能够以更快的响应速度、更高的服务灵活性，帮助客户应对市场变化，助力创新生物药加速上市。这种能力正是其在行业竞争中脱颖而出的核心优势。而对于卡塔尔而言，引入药明生物的CRDMO服务，意味着在参与全球生物制药产业竞争的道路上，获得了一位拥有强大研发实力、严苛质量体系和成本优化能力的战略伙伴。此次药明生物落子中东，不仅在于企业自身的版图扩张，更在于为全球生物药创新构建了更高效的协作网络，为医药创新成果更快惠及全球患者提供了坚实保障。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.9","shortVersion":"4.35.9","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2588026334","isCrawlerRequest":true}